Analysts’ Top Healthcare Picks: AxoGen (AXGN), Irhythm Technologies (IRTC)
TipRanks (Thu, 18-Dec 6:20 AM ET)
Major AxoGen Stock Sales by Company Executives!
TipRanks (Wed, 17-Dec 9:02 PM ET)
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
Globe Newswire (Wed, 17-Dec 7:00 AM ET)
Market Chameleon (Thu, 4-Dec 5:03 AM ET)
Globe Newswire (Wed, 3-Dec 8:01 PM ET)
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Globe Newswire (Tue, 4-Nov 7:00 AM ET)
Axogen’s Double-Digit Growth and Positive Cash Flow Outlook Stand Out as Nerve Repair Market Expands
Market Chameleon (Wed, 29-Oct 7:15 AM ET)
Market Chameleon (Wed, 29-Oct 4:31 AM ET)
Axogen, Inc. Reports Third Quarter 2025 Financial Results
Globe Newswire (Wed, 29-Oct 7:00 AM ET)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
PRNewswire (Sat, 18-Oct 10:00 AM ET)
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Axogen trades on the NASDAQ stock market under the symbol AXGN.
As of December 22, 2025, AXGN stock price climbed to $32.69 with 218,058 million shares trading.
AXGN has a beta of 1.21, meaning it tends to be more sensitive to market movements. AXGN has a correlation of 0.10 to the broad based SPY ETF.
AXGN has a market cap of $1.51 billion. This is considered a Small Cap stock.
Last quarter Axogen reported $60 million in Revenue and $.12 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.09.
In the last 3 years, AXGN traded as high as $34.24 and as low as $3.45.
The top ETF exchange traded funds that AXGN belongs to (by Net Assets): VTI, IWM, VXF, IWO, IHI.
AXGN has outperformed the market in the last year with a return of +120.1%, while the SPY ETF gained +18.9%. In the last 3 month period, AXGN beat the market returning +90.1%, while SPY returned +3.5%. However, in the most recent 2 weeks AXGN has underperformed the stock market by returning -1.9%, while SPY returned +0.2%.
AXGN support price is $30.74 and resistance is $33.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AXGN shares will trade within this expected range on the day.